SELENOP and neoplasm: Research in mammals suggests that the acute phase response (APR), defined as “a complex systemic early-defense system activated by trauma, infection, stress, neoplasia, and inflammation” [53], inhibits selenoprotein P production (reviewed by Burk and Hill [47]).